Metoprolol Z 1a Pharma (Metoprolol Tartrate)

Metoprolol is a selective β1‑adrenergic antagonist that acts on the cardiovascular system to control pressure and rhythm disorders.

• Hypertension: lowers systolic and diastolic blood pressure by reducing cardiac output and renin release.
• Angina pectoris: decreases myocardial oxygen demand, relieving chest pain during exertion.
• Heart failure: improves survival and reduces hospitalisation by moderating heart rate and contractility.
• Cardiac arrhythmias: stabilises abnormal heart rhythms such as atrial fibrillation by slowing conduction through the AV node.

• Metoprolol selectively blocks β1‑adrenergic receptors in the heart, inhibiting the effects of endogenous catecholamines. This results in reduced heart rate, decreased myocardial contractility, and lower renin secretion, which together diminish cardiac workload and blood pressure without significant β2‑mediated bronchial effects.

Metoprolol may cause a range of adverse reactions, from mild to severe. Patients should be aware of both common and rare events.

Common Side Effects

• Fatigue or tiredness
• Dizziness or light‑headedness
• Bradycardia (slow heart rate)
• Cold extremities or peripheral vasoconstriction
• Gastrointestinal upset (nausea, abdominal discomfort)
• Headache

Serious or Rare Side Effects

• Severe bradycardia or heart block
• Marked hypotension
• Bronchospasm, especially in patients with asthma or COPD
• Acute heart failure exacerbation
• Allergic reactions (rash, angioedema, anaphylaxis)
• Depression or mood changes

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients closely.

• Renal impairment: adjust dose or monitor renal function regularly.
• Hepatic impairment: use caution; dose may need reduction.
• Concomitant beta‑blockers: avoid additive cardiac depression.
• Asthma or COPD: assess risk of bronchospasm before use.
• Pregnancy: safety not established; weigh benefits against potential risks.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metoprolol can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Verapamil or diltiazem: may cause profound bradycardia or AV block.
• Abrupt discontinuation of clonidine: can precipitate severe hypertension.
• Insulin or sulfonylureas: may mask hypoglycaemia symptoms.

Moderate Interactions (Monitor Closely)

• ACE inhibitors: may enhance hypotensive effect.
• Diuretics: increase risk of electrolyte disturbances and low blood pressure.
• Lithium: may raise lithium levels, requiring serum monitoring.